PreveCeutical Medical Inc.
PREV
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 9.03% | -158.04% | -13.45% | 14.13% | 19.14% |
| Total Depreciation and Amortization | 2.78% | -27.45% | -20.65% | -12.05% | -2.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.90% | 427.79% | -41.17% | -42.23% | -45.12% |
| Change in Net Operating Assets | -35.40% | 42.48% | 23.44% | -15.32% | 2.74% |
| Cash from Operations | -41.44% | -1,071.89% | -904.08% | -199.22% | -18.57% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 200.00% | -- |
| Cash from Investing | -- | -- | -- | 175.00% | -100.00% |
| Total Debt Issued | 9.77% | -21.61% | -12.68% | -9.34% | 34.54% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 63.16% | 12.10% | -4.00% | 6.55% | 35.05% |
| Foreign Exchange rate Adjustments | -83.33% | 99.49% | 99.14% | 100.00% | -103.87% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,387.50% | -57.14% | -750.00% | -225.00% | 61.90% |